Bortezomib Recruiting Phase 2 Trials for Peripheral T Cell Lymphoma (PTCL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04061772A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma